Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in Shanghai, China, 泰福资本 (TF Capital) is a venture capital firm focused on early-stage biotechnology companies. The firm manages approximately $1 billion in assets under management and has built a portfolio of over 100 companies, including 20 initial public offerings (IPOs).
TF Capital invests in early-stage biotechnology companies, targeting pre-seed to Series C stages. The firm provides capital and strategic expertise, emphasizing global expansion and collaboration within key biopharma hubs.
Notable companies in TF Capital's portfolio include Zai Lab Limited, Hua Medicine, and Henlius, each contributing to advancements in biopharmaceuticals. Other investments include Rendu Biotechnology, Sanyou Medical, and GemPharmatech.
To pitch TF Capital, email your deck to info@tfcapital.net.
TF Capital invests across various stages, including pre-seed, seed, seed-plus, Series A, Series B, and Series C.
The firm primarily focuses on the biotechnology and healthcare sectors, supporting companies that are innovating in these fields.
Founders can pitch by emailing their deck to info@tfcapital.net.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.